Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:28:29.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a change in the number of cohorts evaluating the safety and efficacy of the combination treatment in the Phase 2 (Expansion) of the clinical trial involving lenvatinib plus pembrolizumab for selected solid tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:43.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants in the clinical trial, specifying the health conditions and prior treatments required for inclusion. Previously, no information was provided about the participation criteria.
    Difference
    52%
    Check dated 2024-05-22T21:28:15.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely indicates a shift in the type of intervention or navigation options related to medical and healthcare publications on the webpage.
    Difference
    0.6%
    Check dated 2024-05-01T21:55:28.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.